Taiwan FDA registration e367859244128aa6c34f164cd7ce5020
DangGun A Blood Glucose Monitoring System
TW: 長青糖健血糖監測系統
Taiwan·Risk Class 2·MD·AEON DIAGNOSTIC TECHNOLOGY CORPORATION·Registered Jul 06, 2020 – Nov 06, 2023ExpiredRegistration details
- Analysis ID
- e367859244128aa6c34f164cd7ce5020
- License Form
- Ministry of Health Medical Device Manufacturing No. 006722
Company information
- Manufacturer
- AEON DIAGNOSTIC TECHNOLOGY CORPORATION
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- AEON DIAGNOSTIC TECHNOLOGY CORPORATION
Product details
- Intended Use
- This product is only for in vitro testing, which can quantitatively detect the blood glucose value of fingertip microvascular whole blood, and is not suitable for neonatal testing.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A1345 Glucose Test System
- Import Information
- Produced in Taiwan, China
Dates and status
- Registration Date
- Jul 06, 2020
- Expiry Date
- Nov 06, 2023
About this record
Access comprehensive regulatory information for DangGun A Blood Glucose Monitoring System in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number e367859244128aa6c34f164cd7ce5020 and manufactured by AEON DIAGNOSTIC TECHNOLOGY CORPORATION. The authorized representative in Taiwan is AEON DIAGNOSTIC TECHNOLOGY CORPORATION.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices